Photo by atikahakhtar from unsplash
biosimilar medicines are biological medicine that have been developed to be highly similar and clinically equivalent to an existing biological medicine. Just as patent expiry for conventional drugs has led… Click to show full abstract
biosimilar medicines are biological medicine that have been developed to be highly similar and clinically equivalent to an existing biological medicine. Just as patent expiry for conventional drugs has led to the marketing of generic versions, the expiry of data protection and patents for original biologics has prompted development of biosimilars. This article is protected by copyright. All rights reserved.
Keywords:
medicine;
dermatology;
experience infliximab;
clinical experience;
biosimilar psoriasis;
infliximab biosimilar
Journal Title: British Journal of Dermatology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: British Journal of Dermatology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!